Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice was removed. This update does not affect the study details or data presented on the page.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a government funding lapse and NIH Clinical Center status was added, with links to cc.nih.gov and opm.gov, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary was added to the page. The page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor, site-wide update that does not modify study content or data.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Locations section listing Heilongjiang as a study site. Updated page revision to v3.3.3 (replacing v3.3.2).SummaryDifference0.2%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.